查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496757

药物发现市场：按药物类型、技术、治疗领域和最终用户划分 - 2024-2030 年全球预测

Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Therapeutic Area, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年药物发现市场规模为623.8亿美元，2024年将达711.2亿美元，预计2030年将达到1571.3亿美元，复合年增长率为14.10%。

药物发现是一个多方面且复杂的过程，涉及识别新化合物、阐明生物标的以及确定疾病的治疗潜力。这个过程是开发新药的基础，需要生物学、化学、药理学和医学等各领域的科学家的合作。製药和生物製药行业研发（R＆D）支出的增加以及政府对新兴市场发展的支持正在推动市场成长。此外，管理临床前研究期间产生的大量资料的需求不断增长也推动了市场的成长。药物发现和市场开拓需要巨额资金，而在药物发现中使用动物的严格规范阻碍了市场成长。药物发现领域的技术进步和创新，以及越来越多地使用人工智慧云来创建简化和自动化的药物发现方法，预计将使药物发现有望显着增长。

主要市场统计
基准年[2023] 623.8亿美元
预测年份 [2024] 711.2亿美元
预测年份 [2030] 1571.3亿美元
复合年增长率（%） 14.10%

区域洞察

美洲拥有强大的药物发现基础设施，包括对研发的大量投资、大型製药公司的存在以及完善的法规环境。医疗保健基础设施投资的增加以及应对当地健康挑战的医疗创新需求不断增长，正在加速美洲对药物发现解决方案的需求。在欧洲，先进的医疗保健系统、大量的政府和私人资金以及对国家间创新与合作的高度重视正在推动药物发现的需求。在中东和非洲，由于医疗支出的增加和当地製药业发展的努力，需求正在增加。由于人口众多、经济日益繁荣、医疗基础设施改善、医疗意识不断增强，以及政府支持生物技术和製药行业的倡议不断涌现，亚太地区正迅速成为药物发现市场的主要参与者。

FPNV定位矩阵

FPNV定位矩阵对于评估药物发现市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对药物发现市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在药物发现市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医药及生技製药产业研发费用增加
      • 管理临床前研究期间产生的大量资料的需求日益增加
      • 政府对药物发现平台开发的有利支持
    • 抑制因素
      • 药物发现和开发需要大量资金
    • 机会
      • 药物发现的技术进步与创新
      • 使用 AI 云创建药物发现的简化自动化方法
    • 任务
      • 在药物发现中使用动物的严格标准
  • 市场区隔分析
    • 药物类型：对品牌药和非专利药小分子药物的需求不断增加
    • 技术：扩大生物分析仪器的使用和早期高通量筛检
    • 治疗领域：肿瘤治疗药物开发中对药物发现的需求不断增加
    • 最终用户：製药和生物技术公司更多地利用药物发现来开发新的和改进的药物
  • 市场趋势分析
    • 优先考虑美洲的先进和创新药物发现技术
    • 亚太地区药物开发临床试验的增加和税收优惠的可用性
    • 政府支持欧洲、中东和非洲地区药物发现和开发的资金和倡议
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章按药物类型分類的药物发现市场

  • 生物製药
  • 小分子药物

第七章药物发现市场：依技术分类

  • 生物分析设备
  • 生物晶片
  • 生物资讯学
  • 组合化学
  • 高通量筛检
  • 奈米科技
  • 药物基因组学

第八章按治疗领域分類的药物发现市场

  • 循环系统疾病
  • 消化系统疾病
  • 感染疾病和免疫系统疾病
  • 神经病学
  • 肿瘤学

第九章药物发现市场：依最终使用者分类

  • 学术研究机构
  • 合约调查机构
  • 製药公司

第10章美洲药物发现市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太药物发现市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的药物发现市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Evommune 和 Accutar Biotechnology 宣布开展人工智慧合作
    • IGC Pharma 签署协议，将人工智慧解决方案引入药物发现
    • 筑波大学与Astellas来製药结成策略联盟
    • Mestastop 筹集了 50 万美元，以进一步推进癌症治疗的药物发现
    • Sosei 与 Farm Enable 合作开发新型神经药物
    • 诺和诺德和 Evotech 推出转换加速器
    • Genesis 筹集 2 亿美元用于人工智慧研究
    • Revvity 推出首个科学 SaaS 平台以加速药物和材料开发
    • BenchSci 筹集了 9,500 万美元的 D 轮资金筹措，利用突破性的人工智慧平台 ASCEND 实现大规模药物发现创新
    • Google Cloud 宣布推出人工智慧驱动的解决方案，以安全地加速药物发现和精准医疗
    • Recursion计划斥资8,750万美元收购以强化人工智慧药物发现
    • Eurofins Discovery 收购 CALIXAR，扩大综合药物发现能力和专业知识
    • PerkinElmer 推出多模式盘式分析仪以帮助加速药物发现
    • LabGenius 获得政府创新津贴，以扩展机器学习驱动的药物发现平台 EVA
    • Insight 宣布 FDA核准Pemazyre (Pemigatinib) 作为 FGFR1 重排的髓样淋巴肿瘤 (MLN) 的标靶治疗

第14章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-434CCDA0516F

[189 Pages Report] The Drug Discovery Market size was estimated at USD 62.38 billion in 2023 and expected to reach USD 71.12 billion in 2024, at a CAGR 14.10% to reach USD 157.13 billion by 2030.

Drug discovery is a multifaceted and intricate process that encompasses the identification of novel compounds, the elucidation of their biological targets, and the determination of their therapeutic potential for the treatment of diseases. This process is fundamental to developing new medicines and involves a collaborative effort among scientists from various disciplines, including biology, chemistry, pharmacology, and medicine. Rising research and development (R&D) expenditure in the pharmaceutical and biopharmaceutical industry and favorable government support for developing drug discovery platforms are propelling the market growth. In addition, the increasing need to manage large amounts of data generated during preclinical studies is fueling market growth. The necessity of extensive capital for drug discovery and development and stringent norms for animal usage in drug discovery are hampering market growth. Technological advancements and innovations in drug discovery and the growing use of AI cloud to create a streamlined and automated approach to drug discovery are expected to be poised for significant growth in drug discovery.

KEY MARKET STATISTICS
Base Year [2023] USD 62.38 billion
Estimated Year [2024] USD 71.12 billion
Forecast Year [2030] USD 157.13 billion
CAGR (%) 14.10%

Regional Insights

Americas represents a robust drug discovery infrastructure with significant investments in R&D, a strong presence of pharmaceutical giants, and a conducive regulatory environment. Increasing investment in healthcare infrastructure and growing need for medical innovation to address local health concerns are accelerating the need for drug discovery solutions in the Americas. In Europe, the need for drug discovery is fueled by advanced healthcare systems, substantial government and private funding, and a strong focus on innovation and collaboration across countries. The Middle East and Africa exhibit growing need, with increased healthcare spending and initiatives to foster local pharmaceutical industries. The Asia-Pacific region is rapidly emerging as a significant player in the drug discovery market due to its large population, increasing economic prosperity, improvements in healthcare infrastructure, rising healthcare awareness, and government initiatives to support the biotechnology and pharmaceutical sectors.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Drug Discovery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising R&D Expenditure in the Pharmaceutical & Biopharmaceutical industry
      • Increasing Need to Manage Large Data Generated During Preclinical Studies
      • Favorable Government Support For the Development of Drug Discovery Platforms
    • Market Restraints
      • Requirement of Extensive Capital for Drug Discovery and Development
    • Market Opportunities
      • Technological Advancements and Innovations in Drug Discovery
      • Use of AI Cloud to Create a Streamlined and Automated Approach in Drug Discovery
    • Market Challenges
      • Stringent Norms for the Animal Usage in Drug Discovery
  • Market Segmentation Analysis
    • Drug Type: Growing need for small molecule drugs with branded and generic products
    • Technology: Growing utilization of bioanalytical instruments and high throughput screening for initial drug discovery phases
    • Therapeutic Area: Increasing need of drug discovery for the development of oncology drugs
    • End User: Growing drug discovery use across pharmaceutical and biotechnology companies for developing new and improved drugs
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Drug Discovery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Drug Discovery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration

Evommune, Inc. collaborated with Accutar Biotechnology, Inc., specializing in AI-driven drug discovery, to co-develop therapies for debilitating dermatological conditions. This strategic collaboration intends to leverage Accutar's AI platform to accelerate Evommune's drug discovery and development process, circumventing traditional bottlenecks and paving the way for innovative treatments. [Published On: 2023-11-28]

IGC Pharma signs agreement to adopt AI solutions into drug discovery

IGC Pharma signed an agreement with the University of Los Andes in Colombia to develop and adopt generative artificial intelligence (AI) solutions to detect, develop, and trial new drugs. Under the agreement, the company leverages generative AI to streamline the efficiency of its clinical trials, improve early Alzheimer's disease detection approaches, and enhance drug interaction assessments. [Published On: 2023-11-22]

University of Tsukuba and Astellas Confirm a Strategic Partnership

Astellas Pharma Inc. partnered with the University of Tsukuba to integrate "targeted protein degradation" technology into their portfolio, a pivotal step that enhances their research capabilities. The implementation of this innovative approach aims to transcend the limitations of traditional drug development by strategically degrading disease-causing proteins. [Published On: 2023-11-16]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Drug Discovery Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alacrita Holdings Limited, Astex Pharmaceuticals by Otsuka Pharmaceutical Co., Ltd., Astrazeneca PLC, Atomwise, Inc., BenevolentAI, Bio-Rad Laboratories, Inc., BioSymetrics Inc., Charles River Laboratories International, Inc., Chembridge Corporation, Cloud Pharmaceuticals, Inc., Dalriada Drug Discovery, Deciphera Pharmaceuticals, Inc., Evotec SE, F. Hoffmann-La Roche Ltd., GENFIT SA, Incyte Corporation, International Business Machines Corporation, Intra-Cellular Therapies Inc., Merck KGaA, Microsoft Corporation, NVIDIA Corporation, PerkinElmer, Inc., Pharmacelera SL, Piramal Group, Recursion Pharmaceuticals, Inc., Schrodinger, Inc., Shimadzu Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Type
    • Biologic Drugs
    • Small Molecule Drugs
  • Technology
    • Bioanalytical Instruments
    • Biochips
    • Bioinformatics
    • Combinatorial Chemistry
    • High Throughput Screening
    • Nanotechnology
    • Pharmacogenomics
  • Therapeutic Area
    • Cardiovascular Disease
    • Digestive System Diseases
    • Infectious & Immune system Diseases
    • Neurology
    • Oncology
  • End User
    • Academics & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Georgia
        • Illinois
        • Indiana
        • Michigan
        • New York
        • North Carolina
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising R&D Expenditure in the Pharmaceutical & Biopharmaceutical industry
      • 5.1.1.2. Increasing Need to Manage Large Data Generated During Preclinical Studies
      • 5.1.1.3. Favorable Government Support For the Development of Drug Discovery Platforms
    • 5.1.2. Restraints
      • 5.1.2.1. Requirement of Extensive Capital for Drug Discovery and Development
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements and Innovations in Drug Discovery
      • 5.1.3.2. Use of AI Cloud to Create a Streamlined and Automated Approach in Drug Discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent Norms for the Animal Usage in Drug Discovery
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Drug Type: Growing need for small molecule drugs with branded and generic products
    • 5.2.2. Technology: Growing utilization of bioanalytical instruments and high throughput screening for initial drug discovery phases
    • 5.2.3. Therapeutic Area: Increasing need of drug discovery for the development of oncology drugs
    • 5.2.4. End User: Growing drug discovery use across pharmaceutical and biotechnology companies for developing new and improved drugs
  • 5.3. Market Trend Analysis
    • 5.3.1. Preference for advanced and innovative drug discovery technologies in the Americas
    • 5.3.2. Proliferating number of clinical trials and availability of tax-incentives for drug development across the Asia-Pacific
    • 5.3.3. Supportive government funding and initiatives for drug discovery and development in the EMEA region
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis

6. Drug Discovery Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Biologic Drugs
  • 6.3. Small Molecule Drugs

7. Drug Discovery Market, by Technology

  • 7.1. Introduction
  • 7.2. Bioanalytical Instruments
  • 7.3. Biochips
  • 7.4. Bioinformatics
  • 7.5. Combinatorial Chemistry
  • 7.6. High Throughput Screening
  • 7.7. Nanotechnology
  • 7.8. Pharmacogenomics

8. Drug Discovery Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiovascular Disease
  • 8.3. Digestive System Diseases
  • 8.4. Infectious & Immune system Diseases
  • 8.5. Neurology
  • 8.6. Oncology

9. Drug Discovery Market, by End User

  • 9.1. Introduction
  • 9.2. Academics & Research Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Pharmaceutical Companies

10. Americas Drug Discovery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Discovery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Discovery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration
    • 13.3.2. IGC Pharma signs agreement to adopt AI solutions into drug discovery
    • 13.3.3. University of Tsukuba and Astellas Confirm a Strategic Partnership
    • 13.3.4. Mestastop Raises USD 500k To Further Its Cancer Drug Discovery
    • 13.3.5. Sosei and PharmEnable collaborate on another neurological drug
    • 13.3.6. Novo Nordisk and Evotec launch translational drug discovery accelerator
    • 13.3.7. Genesis Raises USD 200 Million For AI Drug Discovery Research
    • 13.3.8. Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development
    • 13.3.9. BenchSci Raises USD 95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND
    • 13.3.10. Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
    • 13.3.11. Recursion Plans USD 87.5m Acquisitions To Shore Up AI Drug Discovery
    • 13.3.12. Eurofins Discovery Acquires CALIXAR, Expanding Integrated Drug Discovery Capabilities and Expertise
    • 13.3.13. PerkinElmer Unveils Multimode Plate Reader To Expedite Drug Discovery
    • 13.3.14. LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA
    • 13.3.15. Incyte Announces FDA Approval Of Pemazyre (Pemigatinib) As Targeted Treatment For Myeloid/Lymphoid Neoplasms (MLNs) With FGFR1 Rearrangement

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DRUG DISCOVERY MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DISCOVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DRUG DISCOVERY MARKET DYNAMICS
  • FIGURE 7. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DISCOVERY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DISCOVERY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOCHIPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOCHIPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DISCOVERY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DRUG DISCOVERY MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL DRUG DISCOVERY MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS & IMMUNE SYSTEM DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS & IMMUNE SYSTEM DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL DRUG DISCOVERY MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ACADEMICS & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL DRUG DISCOVERY MARKET SIZE, BY ACADEMICS & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES DRUG DISCOVERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 116. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 123. CHINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 124. CHINA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 125. CHINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 126. CHINA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 131. INDIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 132. INDIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 133. INDIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. INDIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 139. INDONESIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 140. INDONESIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 141. INDONESIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. INDONESIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 147. JAPAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 148. JAPAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 149. JAPAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 150. JAPAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 155. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 156. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 157. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 158. MALAYSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 164. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 166. PHILIPPINES DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 172. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 173. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 174. SINGAPORE DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 180. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. SOUTH KOREA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 187. TAIWAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 188. TAIWAN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 189. TAIWAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 190. TAIWAN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. THAILAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 196. THAILAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 197. THAILAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. THAILAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 203. VIETNAM DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 204. VIETNAM DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 205. VIETNAM DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. VIETNAM DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 221. DENMARK DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 222. DENMARK DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 223. DENMARK DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 224. DENMARK DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 229. EGYPT DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 230. EGYPT DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 231. EGYPT DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. EGYPT DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. FINLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 238. FINLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 239. FINLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 240. FINLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 245. FRANCE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 246. FRANCE DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 247. FRANCE DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 248. FRANCE DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 253. GERMANY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 254. GERMANY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 255. GERMANY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. GERMANY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. ISRAEL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 262. ISRAEL DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 263. ISRAEL DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 264. ISRAEL DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 269. ITALY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 270. ITALY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 271. ITALY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 272. ITALY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 278. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 279. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 280. NETHERLANDS DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 285. NIGERIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 286. NIGERIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 287. NIGERIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 288. NIGERIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. NORWAY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 294. NORWAY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 295. NORWAY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 296. NORWAY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 301. POLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 302. POLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 303. POLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 304. POLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. QATAR DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 308. QATAR DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 309. QATAR DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 310. QATAR DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 311. QATAR DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 312. QATAR DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. RUSSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 316. RUSSIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 317. RUSSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 318. RUSSIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 319. RUSSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 320. RUSSIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 324. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 325. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 326. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 327. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 328. SAUDI ARABIA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 333. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 334. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 335. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 336. SOUTH AFRICA DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 339. SPAIN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 340. SPAIN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 341. SPAIN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 342. SPAIN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 343. SPAIN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 344. SPAIN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 345. SWEDEN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. SWEDEN DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. SWEDEN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 348. SWEDEN DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 349. SWEDEN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 350. SWEDEN DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 351. SWEDEN DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 352. SWEDEN DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 356. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 357. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 358. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 359. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 360. SWITZERLAND DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 361. TURKEY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 362. TURKEY DRUG DISCOVERY MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 363. TURKEY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 364. TURKEY DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 365. TURKEY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 366. TURKEY DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 367. TURKEY DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 368. TURKEY DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 369. UNIT